Progress on the roles of MEF2C in neuropsychiatric diseases
- PMID: 34991657
- PMCID: PMC8740500
- DOI: 10.1186/s13041-021-00892-6
Progress on the roles of MEF2C in neuropsychiatric diseases
Abstract
Myocyte Enhancer Factor 2 C (MEF2C), one of the transcription factors of the MADS-BOX family, is involved in embryonic brain development, neuronal formation and differentiation, as well as in the growth and pruning of axons and dendrites. MEF2C is also involved in the development of various neuropsychiatric disorders, such as autism spectrum disorders (ASD), epilepsy, schizophrenia and Alzheimer's disease (AD). Here, we review the relationship between MEF2C and neuropsychiatric disorders, and provide further insights into the mechanism of these diseases.
Keywords: MEF2C; Neurodevelopment; Neuropsychiatric disease; Synapse; Transcription factor.
© 2022. The Author(s).
Conflict of interest statement
Both authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The authors declare that they have no competing interests.
Figures
Similar articles
-
The Mef2c Gene Dose-Dependently Controls Hippocampal Neurogenesis and the Expression of Autism-Like Behaviors.J Neurosci. 2024 Jan 31;44(5):e1058232023. doi: 10.1523/JNEUROSCI.1058-23.2023. J Neurosci. 2024. PMID: 38123360 Free PMC article.
-
Direct targets of MEF2C are enriched for genes associated with schizophrenia and cognitive function and are involved in neuron development and mitochondrial function.PLoS Genet. 2024 Sep 11;20(9):e1011093. doi: 10.1371/journal.pgen.1011093. eCollection 2024 Sep. PLoS Genet. 2024. PMID: 39259737 Free PMC article.
-
Genes influenced by MEF2C contribute to neurodevelopmental disease via gene expression changes that affect multiple types of cortical excitatory neurons.Hum Mol Genet. 2021 May 31;30(11):961-970. doi: 10.1093/hmg/ddaa213. Hum Mol Genet. 2021. PMID: 32975584
-
Involvement of myocyte enhancer factor 2c in the pathogenesis of autism spectrum disorder.Heliyon. 2021 Apr 20;7(4):e06854. doi: 10.1016/j.heliyon.2021.e06854. eCollection 2021 Apr. Heliyon. 2021. PMID: 33981903 Free PMC article. Review.
-
Myocyte enhancer factor 2C and its directly-interacting proteins: A review.Prog Biophys Mol Biol. 2017 Jul;126:22-30. doi: 10.1016/j.pbiomolbio.2017.02.002. Epub 2017 Feb 3. Prog Biophys Mol Biol. 2017. PMID: 28163053 Review.
Cited by
-
Mef2c Controls Postnatal Callosal Axon Targeting by Regulating Sensitivity to Ephrin Repulsion.J Neurosci. 2025 May 21;45(21):e0201252025. doi: 10.1523/JNEUROSCI.0201-25.2025. J Neurosci. 2025. PMID: 40228894
-
Coupling of Alzheimer's Disease Genetic Risk Factors with Viral Susceptibility and Inflammation.Aging Dis. 2024 Oct 1;15(5):2028-2050. doi: 10.14336/AD.2023.1017. Aging Dis. 2024. PMID: 37962454 Free PMC article. Review.
-
The Mef2c Gene Dose-Dependently Controls Hippocampal Neurogenesis and the Expression of Autism-Like Behaviors.J Neurosci. 2024 Jan 31;44(5):e1058232023. doi: 10.1523/JNEUROSCI.1058-23.2023. J Neurosci. 2024. PMID: 38123360 Free PMC article.
-
Citalopram exposure of hESCs during neuronal differentiation identifies dysregulated genes involved in neurodevelopment and depression.Front Cell Dev Biol. 2024 Jul 11;12:1428538. doi: 10.3389/fcell.2024.1428538. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39055655 Free PMC article.
-
Depression and bipolar disorder subtypes differ in their genetic correlations with biological rhythms.Sci Rep. 2022 Sep 21;12(1):15740. doi: 10.1038/s41598-022-19720-5. Sci Rep. 2022. PMID: 36131119 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical